Skip to content

Efficacy and safety of fopropofol disodium for injection in induction of general anesthesia

Efficacy and safety of fopropofol disodium for injection in induction of general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090187
Enrollment
Unknown
Registered
2024-09-25
Start date
2024-11-22
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia

Interventions

Experimental group:fospropofol
Control group:propofol

Sponsors

Peking University Shougang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-65 years old, gender unlimited, weight kg=(height -100)±15%; (2) American Society of Anesthesiologists (ASA) Levels I and II; (3) Subjects undergoing elective general anesthesia cholecystectomy or cholecystolithotomy; (4) non-acute hospitalized subjects who have undergone proper preoperative preparation; (5) Vital signs: respiratory rate =10 and =24 times/min; Blood oxygen saturation (SpO2) =95% when breathing air; Systolic blood pressure (SBP) =90mmHg and =160mmHg; Diastolic blood pressure (DBP) =60mmHg and =100mmHg; Heart rate =55 and =100 beats/min; (6) Can understand the process and method of this study, voluntarily participate in and sign the informed consent

Exclusion criteria

Exclusion criteria: (1) Those who have contraindications to general anesthesia or have a history of anesthesia accidents; (2) Known or suspected allergic or contraindicated to propofol injection and excipients, benzodiazepines, opioids, muscle relaxants, etc.; (3) Patients with craniocerebral loss, intracranial hypertension, stroke, unstable angina pectoris, myocardial infarction; (4) Respiratory insufficiency, obstructive pulmonary disease, presence of a difficult airway, or determination of tracheal intubation difficulty (modified Markov score level III or IV) (5) uncontrolled diabetes or hypertension; (6) severe liver dysfunction or severe renal insufficiency; (7) A history of alcoholism or drug dependence; (8) Abuse or long-term use of narcotic, sedative and analgesic drugs; (9) People with a history of mental illness; (10) Participants in any drug clinical trial within 1 month before screening; (11) Pregnant and lactating women; The reluctance of fertile women or men to use contraception throughout the trial; Subjects (including male subjects) who plan to become pregnant within 1 month after the trial; (12) Subjects who have any other factors deemed unsuitable for participation in this study by the investigator

Design outcomes

Primary

MeasureTime frame
Success rate of anesthesia induction;

Secondary

MeasureTime frame
Systolic blood pressure;Diastolic blood pressure;Mean pressure;Heart rate;Bifrequency index (BIS);Duration of successful induction of anesthesia;Length of absence of eyelash reflex;Operation duration;Intubation duration;PACU stay time;Study drug and alternative drug use;Evaluation of satisfaction degree of anesthesiologists;

Countries

China

Contacts

Public ContactQianqian Guo

Peking University Shougang Hospital

shouganggqq@163.com+86 158 8016 0723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026